BCL2 and breast carcinoma: In this study, DBD-CAP resulted in the increase of the Bax/Bcl-2 ratio in both ER+ and ER- breast cancer cells (Figure 9A) suggesting that the observed cell apoptosis is dependent on alterations of these proteins expression and is associated with the mitochondrial apoptotic pathway.